Work

Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.

Year: 1998

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: N J Vogelzang, S Mani, R L Schilsky, R H Ansari, D Taber, S N Rhinehart, J C Garcia, S C Meyer, R Mick, B E Brockstein, W M Stadler, M J Ratain, E E Vokes

Institution: University of Chicago

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: COOPERATIVE STUDY, Cancer Center Support Grant, PHASE I &CLINICAL PHARMACOKINETICS - ANTI-CANCER AGENTS

OpenAlex ID: W2160966202

FWCI: 0.33

Cites:

Cited by: 5

Related to: 10